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Available online 11 April 2015We have recently identiﬁed lymphatic endothelial cells (LECs) to form two morphologically different popula-
tions, exhibiting signiﬁcantly different surface protein expression levels of podoplanin, a major surface marker
for this cell type. In vitro shockwave treatment (IVSWT) of LECs resulted in enrichment of the podoplaninhigh
cell population and was accompanied by markedly increased cell proliferation, as well as 2D and 3D migration.
Gene expression proﬁles of these distinct populations were established using Affymetrix microarray analyses.
Here we provide additional details about our dataset (NCBI GEO accession number GSE62510) and describe
how we analyzed the data to identify differently expressed genes in these two LEC populations.




ulation 1 versus population 2
thelial cells from foreskin
o differences in FSC and
y donors with authorization
informed consent by the donorDirect link to deposited data
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE62510
Experimental design, materials and methods
Lymphatic endothelial cell isolation
Cells were isolated from healthy donors with authorization of a local
ethics committee and informed consent by the donor. LECs were isolat-
ed from human foreskins via podoplanin selection and immortalized byt (W. Holnthoner).
. This is an open access article understable integration of human telomerase as described [1]. They were
maintained in EGM-2 with 5% fetal calf serum (FCS; GE Healthcare,
Chalfont St Giles, UK) on surfaces coated with 2mg/ml bovine ﬁbronec-
tin (Sigma-Aldrich, St. Louis, USA). LECs were used in passages 35 to 40.
Cell sorting and total RNA isolation
LECs were cultivated to a total number of around 7 × 107 cells. The
cells were enzymatically detached, centrifuged at 100 ×g for 5 min
and resuspended in cold EGM-2 to a concentration of 10 × 106 cells/
700ml. Themixed populationwas sortedwith aMoFlo Astrios cell sort-
er (BD, Franklin Lakes, USA) according to the forward scatter (FSC)
values. The cell suspensions were then centrifuged again at 100 ×g for
5min and themedium supernatant was removed. The cells were resus-
pended in Trizol (Life Technologies, Carlsbad, USA) and chloroform
(Carl Roth, Karlsruhe, Germany) was added. The suspension was
mixed gently, left resting for 5 min at RT and afterwards centrifuged
at 12,000 ×g for 15min at 4 C̊. The RNAwas precipitated by isopropanol
for 10 min at RT. After centrifugation at 12,000 ×g for 15min at 4 C̊, the
RNA pellet was washed with 70% ethanol, dried at RT and resuspended
in sterilewater. Total RNA qualitywas estimated from28S and 18S ribo-
somal RNApeaks on a Bioanalyzer 2100 instrument using the RNA 6000
Nano Kit (Agilent Technologies, Santa Clara, CA).
Standard transcriptome analysis
Isolated RNA from3 technical replicateswas used to produce biotinyl-
ated cRNA using the GeneChip HT 3' IVT Express Kit. Puriﬁed andthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Boxplots of the raw intensities.
Table 1
RMA normalization versus MAS5 normalization, 100 genes with lowest raw p-values
shown for both methods. Genes are ranked from lower to higher p-values for each given
normalization method. For annotated genes, HGNC gene symbols are shown, else
Affymetrix probeset IDs (xxxxx…_at) are given. Bold characters indicate genes common
to both datasets.
Gene symbol or probeset ID,
RMA normalized















































116 B. Schweighofer et al. / Genomics Data 4 (2015) 115–118fragmented cRNA was hybridized to GeneChip Human Genome U133
Plus 2.0 arrays (Affymetrix, SC, CA) following the manufacturer's recom-
mendations. The Affymetrix GeneChip Fluidics Station 450 was used
to wash and stain the arrays with streptavidin-phycoerythrin according
to the standard protocol for eukaryotic targets (IHC kit, Affymetrix).
Arrays were scanned with an Affymetrix GeneChip Scanner 3000. The
resulting .CEL ﬁles were analyzed and normalized with Carmaweb
(https://carmaweb.genome.tugraz.at/carma/). The raw data ﬁles were
normalized using the robust multi-array average method (RMA) (Figs. 1
& 2). Raw and RMA normalized array data were submitted to Gene Ex-
pression Omnibus (GEO) and are available under the accession number
GSE62510.
Enhanced transcriptome analysis to exclude false positive transcripts
As described [2], additional steps were taken to enrich for high qual-
ity data for the ﬁnal selection of a set of differentially expressed genes.


























Gene symbol or probeset ID,
RMA normalized


































MeanM based ranking of combined lists (100 genes each with lowest p-value for RMA
normalization and MAS5 normalization, meanM values averaged). For annotated genes,
HGNC gene symbols are shown, else Affymetrix probeset IDs (xxxxx…_at) are given.
Gene symbol or probeset ID meanM average Raw p RMA Raw p MAS5
1558048_x_at −3.58 1.13E-25 2.15E-02
SYTL4 −2.26 3.26E-16 1.66E-05
SNHG4 −2.19 5.13E-14 1.82E-03
UBE3B −2.09 9.12E-14 3.90E-04
238796_at −2.09 2.44E-12 2.41E-03
MMP7 −2.09 2.57E-12 1.45E-04
1552955_at −2.08 1.16E-11 2.90E-04
DYNC1H1 −2.07 3.14E-11 3.11E-04
INPP4A −2.04 3.45E-11 2.14E-04
NLRP14 −1.98 9.15E-11 4.13E-04
RASEF −1.91 1.93E-10 1.01E-04
ANKRD11 −1.82 2.18E-10 2.05E-01
C17orf52 −1.75 2.35E-10 8.46E-04
224549_x_at −1.74 6.10E-10 2.17E-03
234675_x_at −1.70 1.07E-09 1.73E-02
FLT1 −1.67 1.13E-09 1.28E-04
OR1Q1 −1.66 1.34E-09 2.99E-03
242276_at −1.65 1.69E-09 2.47E-03
227223_at −1.63 3.16E-09 2.25E-03
1570071_at −1.62 5.97E-09 2.60E-05
ZNF638 −1.61 1.29E-08 2.03E-01
NEAT1 −1.56 1.40E-08 7.25E-02
BRD8 −1.52 2.01E-08 1.38E-04
1566042_at −1.50 3.02E-08 8.71E-04
215626_at −1.48 3.17E-08 1.79E-01
FGF11 −1.44 4.78E-08 5.88E-04
232107_at −1.41 7.11E-08 1.61E-04
RASEF −1.41 8.14E-08 3.25E-02
207047_s_at −1.36 1.40E-07 2.89E-03
242881_x_at −1.34 1.60E-07 1.27E-02
PDPK1 −1.33 1.72E-07 8.48E-02
M10098_M_at −1.31 2.04E-07 2.09E-03
M10098_5_at −1.30 2.06E-07 4.04E-02
AFFX-r2-Bs-thr-5_s_at −1.28 2.55E-07 1.05E-02
ITCH −1.28 2.83E-07 3.66E-02
M10098_3_at −1.27 3.09E-07 1.49E-02
TMEM71 −1.27 4.95E-07 5.18E-03
NEAT1 −1.21 7.36E-07 4.53E-02
1558670_at −1.20 7.91E-07 2.30E-03
TCL1A −1.19 9.28E-07 1.68E-04
230750_at −1.18 1.04E-06 2.61E-03
231199_at −1.15 1.06E-06 7.31E-02
HIP1 −1.15 1.08E-06 2.53E-02
RAD21 −1.14 1.16E-06 1.92E-03
AFFX-r2-Bs-dap-5_at −1.12 1.31E-06 7.41E-03
1565717_s_at −1.11 1.33E-06 7.37E-02
SART3 −1.11 1.42E-06 2.05E-02
C11orf53 −1.08 2.35E-06 1.74E-03
C3orf75 −1.07 2.38E-06 1.29E-03
GATC −1.06 2.68E-06 1.09E-01
FOXP4 −1.06 2.69E-06 7.63E-04
CD47 −1.02 2.86E-06 5.20E-02
KLF2 −1.01 3.80E-06 2.44E-03
ATP6V0E1 −1.00 4.23E-06 5.23E-02
AFFX-DapX-5_at −0.99 4.56E-06 2.44E-02
CPNE3 −0.99 5.00E-06 3.30E-03
AFFX-r2-Bs-phe-M_at −0.99 5.14E-06 1.35E-01
SCARB2 −0.98 5.45E-06 1.47E-03
MARCH6 −0.98 7.30E-06 6.71E-02
RANBP2 −0.98 9.07E-06 1.42E-03
CDC27 −0.97 9.56E-06 8.96E-02
MDM4 −0.96 1.01E-05 2.95E-01
MBNL1 −0.95 1.02E-05 6.66E-03
FNIP2 −0.95 1.13E-05 8.85E-02
ZNF207 −0.93 1.15E-05 3.23E-03
TMED2 −0.93 1.19E-05 3.00E-02
230655_at −0.93 1.26E-05 8.48E-02
VEZF1 −0.92 1.48E-05 1.72E-01
ARF6 −0.92 1.51E-05 7.04E-03
P4HB −0.91 1.72E-05 1.84E-03
SFRS6 −0.91 2.10E-05 8.20E-03
RGS20 −0.89 2.14E-05 1.69E-01
(continued on next page)
117B. Schweighofer et al. / Genomics Data 4 (2015) 115–118RMA normalized datasets, restricted to the 40% of the probesets with
the biggest variance over all samples. To exclude potential normaliza-
tion speciﬁc artifacts, a distinct normalization method, MAS5, values
scaled to 200, was applied to the .CEL ﬁles, and differentially expressed
genes were again determined by the moderated t-test (limma) on the
normalized datasets, restricted to the 40% of the probesets with the big-
gest variance over all samples, again in Carmaweb. Depending on these
two normalization methods, two distinct datasets for the 100 best can-
didates (100 lowest p-values) were generated (Table 1). These were
combined and further analyzed in Microsoft Excel.
When screened for maximal differential gene expression in the
podoplaninhigh and podoplaninlow populations, the two normalization
methods (RMA and MAS5) resulted in different top candidate lists.
Only 12 transcripts of the 100 transcripts per list were commonly
found in both lists. They are indicated in Table 1 by bold characters. Of
the best 20 (lowest p-values) RMA-normalized genes, only 5 (25%)
were also found in the 100 most regulated MAS5 normalized genes,
while only 1 (5%) gene of the best 20 MAS5 normalized genes was
found amongst the 100 most regulated RMA normalized genes. These
differences raised concerns about selecting high numbers of false posi-
tive candidates by either normalization method.
To rule out this potential high number of false positive differentially
regulated genes, an average of meanM (log2 transformed fold differ-
ence) and the respective statistic analyses (raw p-values, Bonferroni
adjusted p-value — strong control of the family wise error rate), BH
(Benjamini and Hochberg — strong control of the false discovery rate)
was calculated from the combined lists. Table 2 depicts a ranking of
the combined dataset by their meanM, averaged from both datasets.
To select the most differentially regulated genes, the criteria for the
means from both datasets were a raw p-value of b0.05, a BH value
of b0.5, and a Bonferroni of b1 and only genes more than 2-fold
regulated were selected (average meanM N1 AND b−1). From the re-
maining 40 genes, 10 found to be inversely regulated when comparing
the different normalization methods were excluded as false positives,
and additionally 5 internal Affymetrix probe-sets were excluded from
Table 2 (continued)
Gene symbol or probeset ID meanM average Raw p RMA Raw p MAS5
CAB39 −0.89 2.50E-05 1.56E-01
SNAP23 −0.89 2.86E-05 1.29E-02
AFFX-r2-Bs-thr-M_s_at −0.89 3.01E-05 4.15E-02
PHACTR2 −0.89 3.35E-05 1.07E-01
FOXO3 −0.86 3.40E-05 2.33E-01
NFKBIB −0.85 3.45E-05 1.93E-03
JAG1 −0.85 3.01E-05 3.02E-03
IDH3A −0.84 2.04E-07 2.88E-03
RYK −0.84 7.30E-04 3.29E-03
SMAD7 −0.84 1.13E-05 1.42E-03
ID2 −0.84 2.14E-05 1.66E-05
AFFX-ThrX-M_at −0.84 7.30E-06 2.23E-04
AFFX-M27830_5_at −0.83 7.91E-07 2.47E-03
SERPINE1 −0.83 2.68E-06 9.90E-05
MSI2 −0.82 2.10E-05 2.25E-03
MAT2A −0.82 3.40E-05 3.11E-04
ARHGAP18 −0.81 2.35E-06 1.82E-03
TPR −0.81 6.10E-10 1.38E-04
DLC1 −0.81 1.26E-05 3.19E-03
AFFX-r2-Bs-lys-5_at −0.80 9.56E-06 6.68E-04
241773_at −0.80 9.07E-06 1.19E-03
AFFX-r2-Bs-dap-M_at −0.80 2.86E-05 2.29E-03
SBNO1 −0.80 3.35E-05 1.29E-03
PRIM2 −0.79 1.80E-04 3.90E-04
LIN7C −0.77 3.37E-03 1.61E-04
PTER −0.75 9.28E-07 2.41E-03
LOC100190986 −0.75 1.48E-05 2.42E-03
SCD5 −0.74 4.56E-06 1.28E-04
CXADR −0.74 1.51E-05 2.44E-03
222524_s_at −0.73 2.73E-02 2.99E-03
AFFX-r2-Bs-phe-5_at −0.71 4.23E-06 2.89E-03
220038_at −0.71 8.14E-08 1.74E-03
MGEA5 −0.70 1.19E-05 4.13E-04
SLC7A11 −0.70 5.51E-02 2.47E-03
SKIL −0.70 1.16E-06 2.14E-04
COQ2 −0.68 1.01E-05 7.63E-04
DEAF1 −0.66 3.48E-01 1.45E-04
242787_at −0.65 1.02E-05 1.86E-03
S100A10 −0.63 1.72E-05 6.26E-04
ANKHD1 −0.61 3.45E-05 2.30E-03
HARBI1 −0.39 1.24E-02 1.68E-04
PICALM −0.34 4.95E-07 3.27E-05
C14orf118 −0.34 1.66E-01 2.55E-03
GIMAP6 0.62 5.47E-03 8.46E-04
SAMD1 0.64 5.54E-02 2.84E-03
239355_at 0.73 1.65E-07 9.59E-05
ARHGEF1 0.76 1.50E-01 3.36E-03
CDK1 0.77 2.10E-04 2.90E-04
PRUNE2 0.80 4.50E-07 7.42E-04
CDK1 0.80 1.00E-04 5.88E-04
242611_at 0.81 6.20E-03 1.45E-03
PPP1R3C 0.84 2.08E-07 2.96E-04
KSR2 0.84 3.11E-06 1.14E-03
DIRAS3 0.85 9.99E-06 1.02E-03
PAPPA 0.86 2.41E-06 3.47E-04
IFITM1 0.87 1.88E-05 1.93E-03
LPCAT2 0.92 3.28E-05 1.62E-03
PALMD 0.92 2.05E-06 3.37E-03
BMP6 0.93 6.02E-09 2.22E-03
208451_s_at 0.94 3.29E-03 1.38E-03
SLC16A6 0.95 4.98E-07 1.65E-04
ABCG1 0.96 2.17E-06 3.42E-03
C21orf58 0.96 9.76E-02 2.44E-04
CYP2A7 0.98 1.06E-01 1.28E-03
FMO3 0.99 4.85E-06 3.14E-03
HTR2B 0.99 2.40E-06 3.22E-03
CIDEC 1.01 1.63E-02 1.62E-03
GPX3 1.04 1.86E-07 5.55E-04
ALDH1A1 1.04 1.54E-06 2.49E-03
RFFL 1.07 1.06E-01 2.74E-03
EVI5L 1.10 1.30E-03 2.20E-03
GPX3 1.11 4.54E-07 2.27E-04
VWF 1.12 4.81E-10 2.60E-05
HSP90B1 1.15 6.99E-02 7.65E-05
C19orf21 1.15 5.88E-01 5.44E-04
MGP 1.23 3.44E-10 8.51E-05
Table 2 (continued)
Gene symbol or probeset ID meanM average Raw p RMA Raw p MAS5
FMO3 1.27 5.74E-08 1.86E-03
hCG_1646157 1.27 2.42E-01 7.43E-05
SERPINE2 1.28 1.13E-11 2.58E-03
C19orf34 1.30 8.36E-01 2.40E-03
LOC100130998 1.36 1.76E-01 2.94E-03
C3 1.36 3.63E-01 2.31E-03
234860_at 1.43 2.29E-01 8.71E-04
BMX 1.52 3.55E-14 7.72E-04
1569515_a_at 1.53 1.70E-02 2.15E-03
231005_at 1.53 2.47E-01 1.53E-03
LOC650392 1.62 1.04E-01 1.97E-03
LOC643201 1.68 7.50E-01 1.87E-03
MCM6 1.69 2.18E-01 3.37E-03
1564620_at 1.74 7.50E-01 3.21E-03
P2RX2 1.77 6.47E-01 1.20E-03
ONECUT3 1.77 1.91E-01 1.62E-03
TNK2 1.78 1.96E-01 2.45E-03
HMX2 1.82 3.28E-05 6.26E-04
233687_s_at 1.82 1.88E-05 2.22E-03
244791_at 1.86 9.99E-06 9.90E-05
KLK8 1.94 4.85E-06 1.62E-03
PAPPA 1.95 3.11E-06 1.86E-03
GRM2 1.97 2.41E-06 5.55E-04
241618_at 1.97 2.40E-06 1.65E-04
PSMG4 1.98 2.17E-06 9.59E-05
MTOR 2.01 2.05E-06 1.02E-03
ZNF536 2.03 1.54E-06 2.27E-04
239089_at 2.07 9.71E-02 2.61E-03
SLC7A4 2.08 4.98E-07 1.45E-03
LIMCH1 2.11 4.54E-07 7.65E-05
HORMAD2 2.13 4.50E-07 2.40E-03
ZNF704 2.20 2.08E-07 1.14E-03
SH3GL1P2 2.29 1.86E-07 1.62E-03
CLIP1 2.29 1.65E-07 2.44E-04
LOC100289550 2.34 5.74E-08 7.43E-05
235355_at 2.34 6.02E-09 2.58E-03
RERE 2.35 4.81E-10 2.96E-04
FLJ10213 2.36 3.44E-10 2.15E-03
AKAP14 2.53 1.13E-11 3.27E-05
243281_at 2.56 3.55E-14 7.72E-04
118 B. Schweighofer et al. / Genomics Data 4 (2015) 115–118theﬁnal list. This list, as published in [2] contains 25more than two-fold
differentially regulated transcripts.
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